These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 23076294

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.
    Polyzos SA, Kountouras J, Anastasilakis AD, Litsas I, Kita M, Arsos G, Moralidis E, Terpos E.
    Osteoporos Int; 2011 Jan; 22(1):363-7. PubMed ID: 20407889
    [Abstract] [Full Text] [Related]

  • 23. Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy.
    Craven M, Vajravelu ME, Shekdar KV, Levine MA, Mumm S, Whyte MP, Mancilla EE.
    Bone; 2023 May; 170():116698. PubMed ID: 36740137
    [Abstract] [Full Text] [Related]

  • 24. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 25. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.
    Ang G, Feiglin D, Moses AM.
    Endocr Pract; 2003 Feb; 9(4):280-3. PubMed ID: 14561571
    [Abstract] [Full Text] [Related]

  • 26. Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid.
    Corsello SM, Paragliola RM, Locantore P, Ingraudo F, Ricciato MP, Rota CA, Senes P, Pontecorvi A.
    Hormones (Athens); 2010 Feb; 9(4):338-42. PubMed ID: 21112866
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A tale of three diseases of the bone.
    Kannan S, Mahadevan S, Sathya A, Sriram U.
    Singapore Med J; 2008 Oct; 49(10):e263-5. PubMed ID: 18946593
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [A young woman with headaches and skull anomalies: a long road to the diagnosis 'Paget's disease'].
    Zillikens MC, Ginai AZ, Pols HA.
    Ned Tijdschr Geneeskd; 2006 Sep 30; 150(39):2150-4. PubMed ID: 17059090
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.
    Kaur U, Chakrabarti SS, Gambhir IS.
    Curr Drug Saf; 2016 Sep 30; 11(3):267-9. PubMed ID: 27113952
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.